If you’re a biotech industry executive or investor, chances are you’re in San Francisco this week for the annual J.P. Morgan healthcare conference. And you can expect to hear plenty of lively discussion about gene therapies, a new class of drugs that carries both promise and perils for the biotech industry. Gene therapies are intended to modify a person’s DNA — specifically, by inserting healthy genes into cells to replace faulty or missing ones.
Pricey Gene Therapies Expected To ‘dominate’ Talk At J.p. Morgan Conference
Max Stendahl, Biz Journals
Sun, 01/07/2018 - 2:37pm
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more